Loading...
XNYS
HIMS
Market cap8.60bUSD
Dec 05, Last price  
39.20USD
1D
-2.05%
1Q
-19.02%
IPO
293.97%
Name

Hims & Hers Health Inc

Chart & Performance

D1W1MN
XNYS:HIMS chart
P/E
68.20
P/S
5.82
EPS
0.57
Div Yield, %
Shrs. gr., 5y
56.59%
Rev. gr., 5y
78.03%
Revenues
1.48b
+69.33%
26,679,00082,558,000148,757,000271,878,000526,916,000872,000,0001,476,514,000
Net income
126m
P
-75,243,000-72,064,000-18,114,000-107,659,000-65,678,000-23,546,000126,038,000
CFO
251m
+241.69%
-57,322,000-74,867,000-2,479,000-34,412,000-26,531,00073,483,000251,084,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category; moisturizer, serums, and face wash in the skincare category; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. In addition, it offers medical consultation services, as well as health and wellness products through wholesale partners. The company is based in San Francisco, California.
IPO date
Sep 09, 2019
Employees
651
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT